Cita APA

Mateos, M., Alegre Amor, A., & (GEM-Pethema), S. M. G. (2024). Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance.

Citación estilo Chicago

Mateos, María-Victoria, Adrián Alegre Amor, y Spanish Myeloma Group (GEM-Pethema). Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed By Transplant, KRd Consolidation, and Rd Maintenance. 2024.

Cita MLA

Mateos, María-Victoria, Adrián Alegre Amor, y Spanish Myeloma Group (GEM-Pethema). Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed By Transplant, KRd Consolidation, and Rd Maintenance. 2024.